This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References and Suggested Reading
Hesselwood S, Leung E. Drug interactions with radiopharmaceuticals. Eur J Nucl Med. 1994; 21:348.
Hesselwood S, Keeling DH, and the Radiopharmacy Committee of the European Association of Nuclear Medicine. Frequency of adverse reactions to radiopharmaceuticals in Europe. Eur J Nucl Med. 1997; 24:1179.
Hladik WB III, Ponto JA, Lentle BC, et al. Iatrongenic alterations in the biodistribution of radiotracers as a result of drug therapy: reported instances. In: Hladik WB III, Saha GB, Study KT, eds. Essentials of Nuclear Medicine Science. Baltimore: Williams and Wilkins; 1987:189.
Silberstein EB. Adverse reactions to radiopharmaceutical agents. In: Henkin RE, Boles MA, Dillehay GL, et al., eds. Nuclear Medicine. St. Louis: Mosby; 1996:485.
Silberstein EB, Ryan J, and Pharmacopeia Committee of Nuclear Medicine. Prevalence of adverse reactions in nuclear medicine. J Nucl Med. 1996; 37:185; erratum, page 1064.
Rights and permissions
Copyright information
© 2004 Springer-Verlag New York, Inc.
About this chapter
Cite this chapter
(2004). Adverse Reactions to and Altered Biodistribution of Radiopharmaceuticals. In: Fundamentals of Nuclear Pharmacy. Springer, New York, NY. https://doi.org/10.1007/0-387-21702-9_16
Download citation
DOI: https://doi.org/10.1007/0-387-21702-9_16
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-40360-1
Online ISBN: 978-0-387-21702-4
eBook Packages: Springer Book Archive